BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//European Brain Council (EBC) - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:European Brain Council (EBC)
X-ORIGINAL-URL:https://www.braincouncil.eu
X-WR-CALDESC:Events for European Brain Council (EBC)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221007
DTEND;VALUE=DATE:20221010
DTSTAMP:20260415T002827
CREATED:20220927T134839Z
LAST-MODIFIED:20220927T134839Z
UID:40974-1665100800-1665359999@www.braincouncil.eu
SUMMARY:13th International Autism-Europe Congress
DESCRIPTION:The 13th International Autism-Europe Congress is the first full online Congress with high quality access to its sessions\, presentations\, workshops\, discussion panels and more. You can join in person as well\, in the historical city of Cracow. The Congress brings expertise from around the world to promote a positive vision for autistic people and their families. \n“Happy Journey through Life” is the theme of the Congress – to highlight the importance of taking a lifespan perspective on autism research and practice\, with the promotion of wellbeing for all being the focal point. \nEBC looks forward to presenting the following sessions: \n\nThe value of treatment study: Autism care pathway in Europe (7 October\, 17:00-18:00; Oral Session)\n\nAutism is a lifelong complex neurodevelopmental condition of early onset that affects brain development and behaviour\, characterised by difficulties in social communication\, restricted and repetitive patterns of behaviour\, interests or activities\, and sensory issues which have significant consequences in daily life.  \nThe Value of Treatment (VOT) study results on autism care pathway in Europe will be presented. Early intervention can play a crucial role in the earlier social-communicative and emotional development which will act as a bridge for other more complex abilities. The primary goal of early intervention is to maximize functional independence and quality of life. Despite its great societal and personal impact\, Europe-wide consensus and support for early detection\, diagnosis\, and intervention of autism are lacking.   \n\nAutism with associated epilepsy care pathway in Europe (8 October\, 9:00-13:00; Poster Presentation)\n\nAutism and epilepsy are frequently associated. The prevalence of epilepsy in autism is greater than in the general population. Electroencephalography (EEG) has been used to investigate epilepsy in autism. EEGs are recommended if there is clinical suspicion of epilepsy. However\, the clinical identification of seizures in autism can be challenging because some of the features of seizures such as staring spells\, non-responsiveness and repetitive motor behaviours are also manifestations of autism.  \nAssociated conditions in autism such as epilepsy have a substantial impact on the well being of autistic people and their families\, contribute to reduced quality of life and may increase premature mortality. Despite this\, there is a current lack of studies assessing the journey experienced by autistic children with co-occurring epilepsy and their families in Europe. The VOT study on Autism with associated epilepsy care pathway in Europe will be presented. 
URL:https://www.braincouncil.eu/event/13th-international-autism-europe-congress/
LOCATION:Krakow\, Poland
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221011
DTEND;VALUE=DATE:20221013
DTSTAMP:20260415T002827
CREATED:20220325T132157Z
LAST-MODIFIED:20220804T122043Z
UID:35134-1665446400-1665619199@www.braincouncil.eu
SUMMARY:Brain Innovation Days: Connecting Brains
DESCRIPTION:  \nThis year’s Brain Innovation Days event will centre around Connecting Brains; bringing together the current and future generations of brain research and innovation.  \n\n\n\nThe focus of the 2022 event will be to enable space and opportunity for open discussion and showcasing\, prioritising matchmaking and networking within the community\, particularly of stakeholders who may not have the opportunity to connect in their day-to-day. \n\n\n\n\n\n\nPre-event matchmaking would be encouraged through a dedicated platform in order to facilitate interaction on the day and programme details will be shared between March and May 2022 in order to attract a wider audience and kickstart networking opportunities.  \n\n\n\n\n\n\nThe 2nd Brain Innovation Days Pitch Competition will take place on the day\, with five pre-selected finalists battling live for the jury and public prizes for Best Pitch \n\n\n\n\n\n\nAn Innovation Corner will be set up for companies to showcase their tangible tools and devices and for researchers to present posters\, an area that will be open on the 11th in the afternoon during the EBRA Final Conference and throughout the day on the 12th and host a guided tour during the Networking Reception on 12 October.  \n\n\n\n\n\n\nThe day will host a series of How-To sessions focused on business and networking skills\, a high-level investor panel\, a policy-focused roundtable discussion on research funding\, countless networking opportunities (both in groups and one-on-one) and exciting Brain Talks. \nA pre-event\, 12-episode season 2 of the Brain Talks podcast series will follow the chosen theme of the 2022 BIDs\, also involving members of EBC\, pulling in the perspective of scientists\, clinicians\, patients and more.  \nDiscover the programme and register here!
URL:https://www.braincouncil.eu/event/brain-innovation-days-connecting-brains/
LOCATION:Brussels\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221011T080000
DTEND;TZID=UTC:20221011T140000
DTSTAMP:20260415T002827
CREATED:20220328T093117Z
LAST-MODIFIED:20220804T122055Z
UID:35183-1665475200-1665496800@www.braincouncil.eu
SUMMARY:European Brain Research Area Final Conference
DESCRIPTION:  \nThe European Brain Research Area (EBRA) project partners are delighted to invite you to the upcoming Final Conference\, which will take place on 11 October 2022 in Brussels\, Belgium. \n\n\n\nFour years have already passed and plenty of work is to be presented this coming October\, including the EBRA Landscape Analysis\, the Shared European Brain Research Agenda (SEBRA) as well as the work undertaken by the six EBRA Clusters. The event will be an occasion to bring the wider brain research community and key players together\, to discuss key aims of the project: the current state of brain research in Europe\, increased patient engagement and public awareness\, research infrastructures and data sharing and the future potentials and need for a brain health partnership going forward. \nCollaboration and cooperation in the brain research area remain more important than ever and the EBRA Final Conference will be a major milestone to ensure unification and commitment to the future of brain research in Europe. \nThe EBRA Final Conference will be held in conjunction with the Brain Innovation Days\, taking place on 11-12 October 2022 in Brussels. \nDiscover the programme and register here.
URL:https://www.braincouncil.eu/event/european-brain-research-area-final-conference/
LOCATION:Brussels\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221015
DTEND;VALUE=DATE:20221019
DTSTAMP:20260415T002827
CREATED:20211116T141423Z
LAST-MODIFIED:20221026T122923Z
UID:32607-1665792000-1666137599@www.braincouncil.eu
SUMMARY:EBC at the 35th European College of Neuropsychopharmacology (ECNP) Congress
DESCRIPTION:The annual European College of Neuropsychopharmacology (ECNP) Congress is Europe’s premier scientific meeting for disease-oriented brain research\, annually attracting more than 5\,000 psychiatrists\, neuroscientists\, neurologists and psychologists from around the world. \nThe European College of Neuropsychopharmacology (ECNP) is an independent scientific association dedicated to the science and treatment of disorders of the brain. It is the largest non-institutional supporter of applied and translational neuroscience research and education in Europe. \nEBC was pleased to take part in the ECNP Congress which took place on 15-18 October 2022 in Vienna (Austria) and virtually. Alongside an Exhibition Stand in the exhibition area (booth 16)\, EBC had a campfire session The value of early intervention and continuity of care for mental disorders take place on 17 October at 11:15 – 12:00. The session\, moderated by Prof. Judit Simon\, featured the following presentations: \n\nThe value of early intervention for associated epilepsy in autism by Prof. Celso Arango\, Spain\nThe value of early intervention and continuity of care for mood disorders by Prof. Allan Young\, United Kingdom\n\nAdditionally\, the EBC project the European Brain Research Area (EBRA) was showcased at the congress through a poster. \nWe look forward to the next year’s congress which will take place from 7-10 October 2023 in Barcelona (Spain)!
URL:https://www.braincouncil.eu/event/35th-ecnp-congress/
LOCATION:Vienna\, Austria
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221016
DTEND;VALUE=DATE:20221021
DTSTAMP:20260415T002827
CREATED:20220427T135333Z
LAST-MODIFIED:20221103T084552Z
UID:36088-1665878400-1666310399@www.braincouncil.eu
SUMMARY:European Congress of Neurosurgery 2022
DESCRIPTION:The European Congress of Neurosurgery 2022 (EANS2022) took place on 16-20 October in Belgrade\, Serbia. The European Association of Neurosurgical Societies (EANS) is both an independent federation of European national neurosurgical societies and a fast-developing association of individual neurosurgeons from around the world. \nThe Congress theme – Trends\, Insights\, Innovations: Neurosurgery beyond Technology – addressed the complex relation between technological advances and human ingenuity in the field of neurosurgery. The age of rapid technological progress\, artificial intelligence\, machine learning and virtual reality in the 21st century has brought many benefits to neurosurgery\, but also many challenges. \nAfter two turbulent pandemic years\, the Congress in Belgrade represented the regathering of European and world experts in neurosurgery. It provided an excellent opportunity for sharing experiences and exchanging ideas through the top-level scientific program\, aimed at providing a comprehensive insight into these benefits and challenges and striking the right balance between technology and human (neurosurgeons’) touch. \nEBC President\, Prof. Wolfgang Oertel\, was pleased to take part in the congress and present “EBC and the Brain Policies in Europe” during a plenary “Brain & Spine\, The Official Journal of EANS & EUROSPINE” on 19 October 2022 at 13:50-14:30. \nFind more information on the congress here.
URL:https://www.braincouncil.eu/event/european-congress-of-neurosurgery-2022/
LOCATION:Belgrade\, Serbia
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221017T111500
DTEND;TZID=UTC:20221017T120000
DTSTAMP:20260415T002827
CREATED:20220506T115240Z
LAST-MODIFIED:20221017T074652Z
UID:36340-1666005300-1666008000@www.braincouncil.eu
SUMMARY:The value of early intervention and continuity of care for mental disorders | ECNP Congress
DESCRIPTION:Mood Disorders are a common\, chronic\, severe\, complex and costly group of predominantly recurrent psychiatric illness that can be devastating for the affected individual and their families and impose a high health care related burden. Major depressive disorder and bipolar disorder are the main diagnostic categories in mood disorders. There is a significant clinical need for more effective detection and better delivered treatments for these illnesses. Major depressive disorder accounts for the predominant burden associated with both unipolar and bipolar disorder. However\, both the identification and management of bipolar depression are more challenging\, since bipolar depression differs little symptomatically from unipolar depression and responds poorly to traditional antidepressants\, which may also induce a switch to mania and/or cause rapid cycling. The physical health of people with all mood disorders is compromised and their life expectancy markedly reduced. The aim of a care pathway is to enhance quality of care by improving patient outcomes\, promoting patient safety\, increasing patient satisfaction\, and optimizing the use of resources. \nWith this in mind\, the European Brain Council (EBC) initiated in 2019 a study called the Value of Treatment (VoT) to address diagnostic and treatment gaps for brain (including mental and neurological) disorders. The EBC deemed it necessary to add case studies on mental health conditions such as major depressive disorder and autism. Disease treatment pathways should run from detection in the community through primary and secondary care to specialist clinics. Early intervention and continuity of care are very necessary to effectively manage patients’ mood disorders and overall health.
URL:https://www.braincouncil.eu/event/the-value-of-early-intervention-and-continuity-of-care-for-mental-disorders-ecnp-congress/
LOCATION:Vienna\, Austria
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221018T173000
DTEND;TZID=UTC:20221018T183000
DTSTAMP:20260415T002827
CREATED:20220916T084617Z
LAST-MODIFIED:20230224T095704Z
UID:40694-1666114200-1666117800@www.braincouncil.eu
SUMMARY:Rethinking the early detection and diagnosis of Alzheimer’s disease | Alzheimer Europe Conference
DESCRIPTION:Alzheimer’s disease (AD) is a major unmet medical need that requires innovation to be aligned with public health and health systems‘ needs. AD represents between 60 and%70% of the dementia cases. It is still diagnosed too late\, when the symptoms become more evident as the disease progresses. \nAD is now portrayed as a continuum consisting of three stages: an asymptomatic preclinical phase\, a mild cognitive impairment (MCI) phase\, and dementia. To match this continuum\, current research efforts are now focussing on the earlier stages of the disease (MCI stage)\, when it is believed that a therapeutical intervention at that stage would slow or prevent disease progression. \nThe speakers of the evening symposium “Rethinking the early detection and diagnosis of Alzheimer’s disease”\, set to take place on 18 October 2022 from 17:30-18:30 (Bucharest time) at the Alzheimer Europe Conference\, will present a research-driven project RETHINKING Alzheimer’s disease. The project is led by the European Brain Council (EBC) in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA) with the aim to identify the roadblocks to early detection and diagnosis of AD and will propose new clinical pathways building bridges between all stakeholders to improve the current situation and prepare for the future. \nSpeakers’ biographiesKevin Quaid\, Vice-Chairperson\, European Working Group of People with Dementia  \nLimerick native Kevin Quaid was diagnosed with Lewy Body Dementia in 2017 aged 53\, after being diagnosed firstly with Parkinsons. He is a member of the Irish Dementia Working Group as well as vice chair of the European Working Group of People with dementia and co founder of Lewy body Ireland  \nKevin is an avid GAA fan and speaks about the fighting spirit of the Limerick hurling team in 2018 and the fact they never gave up. He brings that same spirit to his life with dementia.  \nKevin is married to Helena. He has three children\, three stepchildren and five grandchildren. This family man is an adventurer who spent time in Australia and loves to travel.  \nAfter his diagnosis Kevin realised there was a lack of information about his particular form of dementia and wrote a book called “Lewy Body Dementia\, Survival and Me”. He was one of the first patients in the world to write a book about Lewy Body Dementia from the patients point of view as well as his families point of view\, He has since written a second book called “I am KEVIN not Lewy” . He is now an active advocate and through his work with the Irish Dementia Working Group supported by The Alzheimer Society of Ireland raises awareness about the condition through speaking engagements and media appearances. \nWiesje van der Flier\, Scientific Director\, Alzheimer Center Amsterdam  \nWiesje van der Flier (1975) is full professor and scientific director of Alzheimer center Amsterdam at Amsterdam UMC\, the Netherlands\, where she works since 2004. She studied neuropsychology at the University of Utrecht. In addition\, she is clinical epidemiologist. She leads the Amsterdam Dementia Cohort\, an ongoing memory-clinic based cohort including over 6000 patients with deep phenotyping (MRI\, EEG\, CSF biomarkers\, and PET) and linked biobank (blood\, DNA\, CSF). The Amsterdam Dementia Cohort is at the basis of many of the studies performed at Alzheimer center Amsterdam. Van der Flier has been (co)promotor of >20 theses and is currently supervising ~10 PhD projects. Van der Fliers main research areas are looking for the origin of AD\, diagnosis&prognosis\, and intervention&prevention. Van der Flier leads ABOARD (A Personalized Medicine Approach for Alzheimer's Disease)\, a Dutch public-private partnership of than 30 partners. Together with colleague Philip Scheltens\, she has written a book\, het Alzheimermysterie\, which was published by the Arbeiderspers.  \nLenka Krajčovičová\, Assistant Professor\, Masaryk University  \nLenka Krajčovičová has a PhD in neurology at Masaryk University in Brno (Czech Republic). Her scientific topics include neurodegenerative disorders – Parkinson´s disease and Alzheimer´s disease in particular\, movement disorders\, cognitive disorders.  \nShe has been involved in numerous research projects such as Microbiome in neurodegenerative diseases with cognitive impairment (Czech national recovery program)\, Diagnostics of Lewy body diseases in the prodromal stage based on multimodal data analysis\, supported by Ministry of Health of the Czech Republic\, Modulation of cognition and brain connectivity by noninvasive brain stimulation in patients with mild cognitive impairment due to Alzheimer's disease\, supported by Ministry of Health of the Czech Republic\, Effect of intensive dance-exercise intervention on cognitive function and changes of brain plasticity in healthy seniors and patients with mild cognitive impairment in early stage of Alzheimer´s disease\, supported by Ministry of Health of the Czech Republic and Pre-clinical genotype-phenotype predictors of Alzheimer´s disease and other dementia (APGeM)\, supported by EU Joint Program – Neurodegenerative Disease Research.   \nLenka Krajčovičová is a member of the Czech medical society\, the Czech neurological society\, the Section of cognitive neurology\, the Section of extrapyramidal neurology and the Czech society for clinical neurophysiology.    \nLydia Lanman\, Senior Global Policy Leader\, Roche  \nLydia Lanman is a senior Global Policy Leader at Hoffmann-La Roche and is responsible for leading Roche efforts across a variety of global health policy areas. Her area of expertise is in brain health and Alzheimer's disease.  \nLydia joined the pharmaceutical industry in Canada in 2007\, where she has led a variety of national policy\, government relations and market access efforts at two pharmaceutical firms. Prior to joining pharma\, Lydia worked in various senior advisory roles in Canada\, providing strategic advice directly to Ministers and Deputy Ministers of Health\, both federally and provincially\, on the development of health care policy\, health system design and intergovernmental relations.  \nLydia holds a Bachelor of Arts in Political Science and a Master of Arts in Political Science and Public Health\, both from the University of Alberta. Her graduate work focused primarily on Canadian and international health care reforms. \nFor privacy reasons YouTube needs your permission to be loaded. For more details\, please see our Privacy Policy.I Accept
URL:https://www.braincouncil.eu/event/alzheimer-europe-conference-rethinking-the-early-detection-and-diagnosis-of-alzheimers-disease/
LOCATION:Bucharest\, Romania
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221101
DTEND;VALUE=DATE:20221105
DTSTAMP:20260415T002827
CREATED:20220803T131325Z
LAST-MODIFIED:20220804T122329Z
UID:39314-1667260800-1667606399@www.braincouncil.eu
SUMMARY:International Congress for Ataxia Research (ICAR)
DESCRIPTION:The International Congress for Ataxia Research (ICAR)\, to be held on 1-4 November 2022\, will take place in Dallas\, Texas (USA). \nThis Congress will combine the best of our organizations’ popular research meetings\, including NAF’s Ataxia Investigators Meeting (AIM) and the International Ataxia Research Conference (IARC)\, co-led by FARA\, Ataxia UK\, GoFAR\, and other partner organizations. ICAR 2022 will include plenary sessions\, poster sessions\, breakouts and workshops. \nFeatured topics include: gene discovery\, disease mechanisms\, cerebellar non-motor circuits and functions\, emerging and existing therapeutics\, biomarkers and late breaking research. ICAR will also feature workshops with practical demonstrations\, discussions on challenges of new and established technologies\, and sessions specifically designed by and for junior investigators. \n 
URL:https://www.braincouncil.eu/event/international-congress-for-ataxia-research-icar/
LOCATION:Dallas\, TX\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221103
DTEND;VALUE=DATE:20221106
DTSTAMP:20260415T002827
CREATED:20221109T102423Z
LAST-MODIFIED:20221109T112310Z
UID:42269-1667433600-1667692799@www.braincouncil.eu
SUMMARY:Mental Health Week events in Greece – with special focus on child and adolescent mental health
DESCRIPTION:EBC as a member of the pan-European Mental Health Coalition (*) working package on mental health and well-being of children\, adolescents and youth and in the framework of the joint Value of Treatment study on anorexia nervosa\, autism and depression in Europe participated online in the Mental Health Week meeting that took place in Athens (Greece) on 3-5 November 2022.  \nThe meeting aimed to share good practices in improving mental health and well-being for children and adolescents\, to review progress to date and to refine priority actions for the future. It included interactive workshops to gather inputs from young people on developing a quality-of-care framework for child and adolescent mental health in Europe. \n(*) The Coalition\, launched in September 2021\, is a network of individuals and organisations committed to ensuring that every person in the European Region has access to the resources needed for good mental health. It does so by harnessing the collective wisdom\, expertise\, and know-how of its more than 200 members\, guided by the WHO European Framework for Action on Mental Health 2021–2025. A 2nd meeting of the Pan-European Mental Health Coalition “Local Action\, Regional Transformation” will take place on 23-24 November 2022 in Ankara (Turkey). This meeting will show examples of good practices in national contexts\, including Turkey\, as well as looking to the future\, and discuss how to continue towards mental health service transformation. \nLook back at the programmeRead the EBC Call to Action on Improving Mental Health Care in Europe
URL:https://www.braincouncil.eu/event/mental-health-week-events-in-greece-with-special-focus-on-child-and-adolescent-mental-health/
LOCATION:Athens\, Greece
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221115T090000
DTEND;TZID=UTC:20221115T190000
DTSTAMP:20260415T002827
CREATED:20220823T085711Z
LAST-MODIFIED:20220823T085711Z
UID:39957-1668502800-1668538800@www.braincouncil.eu
SUMMARY:EU Health Summit: Towards an EU Health Union
DESCRIPTION:The EU Health Coalition is delighted to invite you to its 3rd EU Health Summit to map the future of the European Health Union. \nThe event will build on the stark lessons learned from COVID-19 and discuss how to go beyond the status-quo in health\, seizing opportunities to make positive changes. It will ask what it takes to build a successful EU Health Union centered on people\, innovation\, and value-based care so that Europeans’ health is better protected and our health systems are performant and resilient. \nThe EU Health Summit will reflect on progress towards reaching the EU Health Coalition’s 2020 recommendations and look at how we can power the change towards a stronger Health Union. \nRegister now!
URL:https://www.braincouncil.eu/event/eu-health-summit-towards-an-eu-health-union/
LOCATION:Brussels\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221123
DTEND;VALUE=DATE:20221125
DTSTAMP:20260415T002827
CREATED:20221109T104318Z
LAST-MODIFIED:20221125T145215Z
UID:42276-1669161600-1669334399@www.braincouncil.eu
SUMMARY:Local action\, regional transformation: WHO Pan-European Mental Health Coalition Meeting
DESCRIPTION:WHO/Europe held the second meeting of its Pan-European Mental Health Coalition on 23–24 November 2022 in Ankara\, Turkey\, jointly hosted with the fourth Annual Conference on Social Inclusion of Persons with Mental Disabilities. Held in hybrid format\, the conference aimed to leverage regional momentum and continue advocating for the necessary actions to improve mental health systems across the WHO European Region. \nSubtitled “Local action\, regional transformation”\, the second Coalition meeting brought together government representatives; professionals working at the local\, national and regional levels; people living with mental health conditions; academics; and others\, to share good practice examples in national contexts and continue the development of the Coalition’s key priority areas. \nEBC\, as a member of the pan-European Mental Health Coalition\, was pleased to participate in the meeting. \nDr Hans Henri P. Kluge\, WHO Regional Director for Europe\, connected from Ukraine\, opening the WHO Pan-European Mental Health Coalition Meeting. \nPetr Winkler\, Director of the National Institute of Mental Health (Czech Republic) and one of the experts involved in the Value of Treatment case study on schizophrenia\, met with Vinciane Quoidbach\, Research Project Manager at EBC.
URL:https://www.braincouncil.eu/event/local-action-regional-transformation-who-pan-european-mental-health-coalition-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221206T140000
DTEND;TZID=UTC:20221206T160000
DTSTAMP:20260415T002827
CREATED:20221025T180039Z
LAST-MODIFIED:20230102T141247Z
UID:41602-1670335200-1670342400@www.braincouncil.eu
SUMMARY:Psychedelic-assisted therapies in the treatment of brain disorders
DESCRIPTION:The Psychedelic Access and Research European Alliance and European Brain Council were pleased to hold the event\, “Psychedelic-assisted therapies in the treatment of brain disorders”\, hosted by MEPs Jarosław Duda (EPP\, PL) and Alex Agius Saliba (S&D\, MT) in the European Parliament on 6 December 2022 at 14:00 –16:00 CET. \nUnderstanding our brain is an enormous task and brain research is extremely complex. Despite huge scientific efforts\, mental\, neurological and substance use disorders are leading the list of diseases without a known cure. Estimates show that – at the current pace – by 2040 e can prevent only a small proportion of a burden from neurological and mental health conditions: 23% and 14% respectively. \nHowever\, innovations that completely change the lives of patients continue to emerge and psychedelic-assisted therapies are one such area. Rapidly growing\, rigorous\, and compelling body of research demonstrates that these therapies can be a potent new class of treatments for mental\, neurological and substance use disorders. \nIn 2021 alone – ground-breaking findings were published in prestigious journals such as Lancet\, Nature Medicine\, and New England Journal of Medicine. For example\, a phase 3 clinical trial demonstrated that 67% of participants who received the MDMA-assisted therapy no longer had PTSD after two months of therapy. A double-blinded randomized study published in August 2022 in JAMA Psychiatry found that – with 2 doses of psilocybin paired with psychotherapy – nearly half of participants had stopped drinking entirely by the end of the 8-month trial. Psychedelics are also increasingly being researched in the context of neurological disorders such as headaches. \nWhile no treatment is without risks\, research shows that psychedelic-assisted therapy is generally physiologically and psychologically safe when delivered in controlled and supportive settings and psychedelic compounds are non-toxic and non-habit forming. \nThe President Biden Administration’s letter from May 2022 anticipates that US regulators will approve MDMA and psilocybin within the next two years for treatments of PTSD and depression. The administration is “exploring the prospect of establishing a Federal Task Force to monitor and address the numerous complex issues associated with these substances”. In the next few years\, millions of Europeans may be eligible for a prescription of psychedelic therapies and we need to start preparing for this now. \nAgendaLook back at the event
URL:https://www.braincouncil.eu/event/psychedelic-assisted-therapies-in-the-treatment-of-brain-disorders/
LOCATION:European Parliament\, Rue Wiertz 60\, Brussels\, 1047\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221207T160000
DTEND;TZID=UTC:20221207T173000
DTSTAMP:20260415T002827
CREATED:20221201T123233Z
LAST-MODIFIED:20230102T134701Z
UID:42963-1670428800-1670434200@www.braincouncil.eu
SUMMARY:Rare Neurological Diseases in the EU: The Importance of Early Diagnosis and Real World Evidence to Drive Better Patient Outcomes
DESCRIPTION:On 7 December 2022 at 16:00-17:30\, the European Alliance for Patient Access (EAfPA)\, with support of the European Brain Council (EBC) and European Federation of Neurological Associations (EFNA)\, hosted an event in the European Parliament on Rare Neurological Diseases in the EU\, exploring the importance of early diagnosis and real-world evidence (RWE) to drive better patient outcomes. \nHosted by MEP Tilly Metz (Greens/EFA\, Luxembourg)\, European stakeholders convened to discuss the critical need for improved access to care\, services\, and treatment for patients living with rare neurological diseases. Conversations were centred on revisions of current legislation to meet the needs of patients living with a rare neurological condition\, as well as the importance of RWE and early diagnosis. \nFrédéric Destrebecq\, EBC Executive Director\, presented the Value of Treatment for rare neurological and neurometabolic diseases case study results and 2022 call to action. \nRead moreRegistration is now closed. The draft agenda is included below: \nDraft Agenda - Rare Neurological Diseases in the EU- The Importance of Early Diagnosis and Real World Evidence to Drive Better Patient Outcomes
URL:https://www.braincouncil.eu/event/42963/
LOCATION:European Parliament\, Rue Wiertz 60\, Brussels\, 1047\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20221208T140000
DTEND;TZID=UTC:20221208T160000
DTSTAMP:20260415T002827
CREATED:20221121T115227Z
LAST-MODIFIED:20230103T101246Z
UID:42621-1670508000-1670515200@www.braincouncil.eu
SUMMARY:‘The Future of Brain Health: Clinically Informed & Patient-Centred Brain Research’
DESCRIPTION:EBC Member\, the European Academy of Neurology\, hosted an event on ‘The Future of Brain Health: Clinically Informed & Patient-Centred Brain Research’ on 8 December in the European Parliament. Held under the auspices of the Czech Presidency of the Council of the European Union and hosted by MEP Ondřej Knotek\, the event highlighted the importance and need for research\, as well as the main priorities and gaps within neurology\, which if addressed will have major impact on brain health. \nThe event took place in-person at the European Parliament in Brussels on December 8 from 14:00 to 16:00 CET. \nEBC President\, Prof. Wolfgang Oertel\, took part in the panel discussion “The Future of Brain Research in Europe: Key Priorities and How They Can Be Addressed”\, together with Orla Galvin (European Federation of Neurological Associations)\, Paweł Świeboda (EBRAINS) and Frances-Catherine Quevenco (Women’s Brain Project). The panel was moderated by Jacqui Thornton. \nLook back at the event and watch the full recording and the highlights video below. \nFull Recording of the Future of Brain Health EventHighlights video
URL:https://www.braincouncil.eu/event/the-future-of-brain-health-clinically-informed-patient-centred-brain-research/
LOCATION:European Parliament\, Rue Wiertz 60\, Brussels\, 1047\, Belgium
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230124T123000
DTEND;TZID=UTC:20230124T140000
DTSTAMP:20260415T002827
CREATED:20221110T141754Z
LAST-MODIFIED:20230111T074620Z
UID:42329-1674563400-1674568800@www.braincouncil.eu
SUMMARY:Launch event of the RETHINKING Alzheimer’s disease White Paper
DESCRIPTION:The launch event of the RETHINKING Alzheimer’s disease White Paper\, calling for change in Alzheimer’s care\, will take place virtually on 24 January 2023 at 12:30 – 14:00. \nThe European Brain Council (EBC)\, in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA)\, will present its White Paper “RETHINKING Alzheimer’s disease: Detection and diagnosis“. This paper is the first of EBC’s “RETHINKING Alzheimer’s disease” project\, looking at how to improve the detection\, diagnosis\, care and monitoring of Alzheimer’s disease. \nMoving Towards a new Alzheimer’s Disease diagnostic pathway in Europe\nOur understanding of the progression of Alzheimer’s disease has improved significantly\, leading to the development of advanced diagnostics and treatment approaches. To keep people living with Alzheimer’s disease in better health for longer\, healthcare systems must be equipped to accurately diagnose the disease earlier and enable earlier access to treatment and support.  \nWe’re at a crossroads in the management of Alzheimer’s disease\, with new potential treatments on the horizon. Current healthcare systems are not set up to diagnose and treat the condition early enough to realise the value of upcoming advanced therapeutics\, and the benefits they could deliver for broader society.   \nThis must change now\, with the support of clear policies that enable timely detection and timely clinical and accurate pathological diagnosis of Alzheimer’s disease.  \nRethinking the detection and diagnosis of Alzheimer’s disease\nJoin the discussion and learn why an accurate and timely diagnosis is so crucial to advancing the science and our understanding of Alzheimer’s. You can look forward to opening remarks from MEP Sirpa Pietikäinen (EPP\, Finland) and a keynote speech highlighting the value of an early diagnosis from a patient perspective. \nThe keynote will be followed by a panel discussion\, moderated by Laura Campo (Eli Lilly and Company)\, featuring experts involved in the RETHINKING Alzheimer’s disease project\, Kristian Steen Frederiksen (European Academy of Neurology)\, Maria Teresa Ferretti (Women’s Brain Project) and Linus Jönsson (Karolinska Institutet). The panel will emphasise a clear need for new clinical pathways building bridges between all stakeholders to improve the current situation and prepare for the future. \nThe event will conclude with a high-level policy panel\, moderated by Frédéric Destrebecq (European Brain Council)\, with MEP Tomislav Sokol (EPP\, Croatia)\, MEP Deirdre Clune (EPP\, Ireland)\, Andrzej Rys (Directorate-General for Health and Food Safety – DG SANTE\, European Commission) and Dr. Neerja Chowdhary (World Health Organization). \nHave your say on how to improve Alzheimer’s care\nRegister now and share your views on how Alzheimer’s care can be improved by completing a short survey\, which will be circulated to all registered participants prior to the event.\n\nThe results of the survey will feed directly in the policy recommendations of the RETHINKING Alzheimer’s disease White Paper\, which will be released following the event. Preliminary results will also be shared to allow for exchange on the needed strategies and plans for change in the Alzheimer’s care pathway.\n\nJoin the discussion and be part of rethinking the way we approach Alzheimer’s disease.\nPractical information\nDate: Tuesday\, 24 January 2023\nTime: 12:30 – 14:00 (Brussels time)\nLocation: livestream\nRegistration: Please register here \nAll participants must register before attending this event. Once registered\, Zoom instructions will be sent via email closer to the date. \nDiscover the programmeRegister nowRETHINKING Alzheimer's disease - Launch event of the White Paper - Programme
URL:https://www.braincouncil.eu/event/launch-event-of-the-rethinking-alzheimers-disease-white-paper/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230215
DTEND;VALUE=DATE:20230216
DTSTAMP:20260415T002827
CREATED:20230131T141001Z
LAST-MODIFIED:20230224T100110Z
UID:44801-1676419200-1676505599@www.braincouncil.eu
SUMMARY:Europe Rare Disease Summit 2023
DESCRIPTION:With a new Rare Disease International Day coming up\, Bamberg Health in collaboration with key actores of the industry\, is organizing the Europe Rare Disease Summit in Madrid (Spain) and virtually. \nThe objective of the Summit was to discuss the key trends and topics relating to diagnostics and treatments for Rare Diseases\, as well as the challenges to timely and equitable access to orphan drugs\, and European initiatives for access\, research and innovation programs to improve the lives of patients with rare diseases. The event wil be attended by governmental authorities and regulatory agancies from across the region\, large public and private hospital groups\, research centers\, pharmaceutical and patient associations\, scientifc societies and health professionals from all over the region. \nEBC was delighted to be invited as a contributor this year\, with EBC Research Project Manager\, Vinciane Quoidbach\, who took part in the 1st Panel ‘National Plans\, Policies and Government Initiatives Against Rare Diseases’ from 09:15 to 10:00. \nTo access the program and whole agenda please click here
URL:https://www.braincouncil.eu/event/europe-rare-disease-summit-2023/
LOCATION:Madrid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230215T140000
DTEND;TZID=UTC:20230215T190000
DTSTAMP:20260415T002827
CREATED:20230213T103050Z
LAST-MODIFIED:20230213T103437Z
UID:45184-1676469600-1676487600@www.braincouncil.eu
SUMMARY:Mind-body Approaches to Boost Brain Capital
DESCRIPTION:The world is increasingly relying on brain capital\, where a premium is put on brain skills and brain health (e.g. individual’s cognitive\, emotional\, and social brain resources). Investing in building brain capital is fundamental to meet modern societal challenges and to drive innovation. However\, understanding the brain\, brain health\, and brain disorders is essential to improving health and quality of life. It also offers a pathway to understanding the new economic and social reality. \nOn the 15th February 2023\, at 14:00 – 19:00 CET\, EMEA will hold the workshop Mind-body Approaches to Boost Brain Capital event as part of the BioRegion Health Innovation Week organized by BioCat\, in collaboration with Brain Capital Alliance\, OECD Neuroscience-inspired Policy Initiative\, Center for Health and Bioscience at The Baker Institute for Public Policy at Rice University\, University of Colorado Denver’s Imaginator Academy\, and European Brain Council. The event will be broadcast live on EMEA social media. \nThis workshop aims to deep dive into examples which improve brain health and brain skills\, respectively. We will explore exercise as an approach to improving brain health and creativity as a key brain skill allowing for an in-depth discussion on the links between exercise and creativity. The workshop aims to bring in a mixture of academic\, clinical\, economic\, policy and private sector actors to generate new\, scalable solutions and pilot projects that can drive a new economic dynamic that is needed to enhance wellbeing and resilience. \nEBC is pleased to be a contributor to the event with Frédéric Destrebecq\, EBC Executive Director\, taking part in a session “Intersections between exercise and creativity to boost brain capital” at 17:30-19:30. This session has the aim to explore the powerful links between exercise and creativity to accelerate progress on brain capital. In a recent study\, it was found that\, in general\, being more active meant being more creative demonstrating a link between the two. Exercise can boost brain health and creativity can boost brain skills\, making the two activities potentially groundbreaking in driving a new economic dynamic for wellbeing and resilience.
URL:https://www.braincouncil.eu/event/mind-body-approaches-to-boost-brain-capital/
LOCATION:Barcelona\, Spain
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230228T093000
DTEND;TZID=UTC:20230228T120000
DTSTAMP:20260415T002827
CREATED:20230103T120837Z
LAST-MODIFIED:20230213T123720Z
UID:43897-1677576600-1677585600@www.braincouncil.eu
SUMMARY:BRAINTEASER Mid Term Workshop: Data science and artificial intelligence for supporting the care and cure of amyotrophic lateral sclerosis and multiple sclerosis patients
DESCRIPTION:BRAINTEASER is a data science project\, which the European Brain Council is part of\, employs AI-based clinical software and mobile apps to support patients with amyotrophic lateral sclerosis and multiple sclerosis\, their clinicians and families. \nWe have developed a prototype app-based solution with the aim of bridging the gap between hospital- and home-care. Through the app\, the patients can send data and questions to the clinicians and receive help and suggestions. \nWe are also integrating wearable app sensor data collected through smart watches and air-quality data collected through wearable sensors. The first\, together with the patient input\, helps clinicians determine the patient status. The second is useful to study the possible impact of the environment on disease exacerbation. \nWe have adopted an open-science paradigm. We respect patient data confidentiality and ownership (data are fully anonymous)\, and\, at the same time\, challenge the scientific community to compare\, discuss and openly publish their systems and solutions\, including those developed by BRAINTEASER. \nWe have already organised a first open evaluation challenge in September 2022 with the aim of predicting disease prognosis in ALS\, and the following is coming in Fall 2023\, when we will discuss analogous AI solutions for MS and the possible impact of the environment. \nThese AI models will be then used to give integrated and augmented information to the clinicians\, improving prognostication and intervention timing in routine clinical practice. \nAs the project has reached the halfway stage\, on the 28th February 2023 the Consortium has planned its mid-term workshop. \nThe organisation of this event comes at the end of the first phase of the project and will serve as a basis to launch the second phase or “pilot phase” that will focus on transforming the current health approach from a reactive to a predictive system focused on risk prediction\, patient stratification and prognosis. \nThe workshop will also serve as a place for reflection on the importance of transformative research\, with a view to identifying the opportunities that arise from the National Plan for Recovery and Resilience and the related strategic lines of use of the funds envisaged by the Next Generation EU Programme. \nThe event\, which can be also attended online\, will be held in the prestigious location of the University of Padua Botanical Garden\, Italy. \nThe BRAINTEASER Mid Term Workshop Full Programme can be accessed here. \nYou can register here to join the event online\, but if you wish to join us in presence please click here! \nFinal programmeJoin onlineJoin in person
URL:https://www.braincouncil.eu/event/brainteaser-mid-term-workshop-data-science-and-artificial-intelligence-for-supporting-the-care-and-cure-of-amyotrophic-lateral-sclerosis-and-multiple-sclerosis-patients/
LOCATION:Padua\, Italy
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230316T090000
DTEND;TZID=UTC:20230316T170000
DTSTAMP:20260415T002827
CREATED:20221216T082303Z
LAST-MODIFIED:20230302T105913Z
UID:43441-1678957200-1678986000@www.braincouncil.eu
SUMMARY:Global Partnerships in Brain Research | Brain Awareness Week 2023
DESCRIPTION:Brain Awareness Week 2023: Global Partnerships in Brain Research  \nBrussels\, Belgium | 16 March 2022 | 10:00-17:00 \nEnhancing global collaboration in the domain of research and innovation is key for effectively addressing today’s societal challenges and improving the health and well-being of citizens. This is particularly true for brain disorders\, including both neurological and mental conditions\, which are widespread and highly disabling diseases that are often difficult to treat. It is crucial to explore how global research collaboration can support brain research in a meaningful way\, to the benefit of people living with brain conditions across the globe. \nUnderstanding the brain is not just to tackle a “burden”. It is also to allow people to thrive; to live healthily\, to power our economies and to build for future generations. Investing in the brain and brain research is critical. \nWith plenty of high-caliber brain research underway across the world\, the fostering of concrete global partnerships and alliances for brain research is urgently needed – sharing knowledge and learning from peers\, working in collaboration rather than silos and strengthening alignment across diverse public and private entities to structure and track investments for the benefit of international research and the health of all populations. Brain health is global and should not be tackled solely at the regional level – but at a global level\, particularly as our world grows increasingly borderless. Competition in this space would be futile to address the growing burden of brain disorders and the need for improved brain health in society. \nThis high-level\, international event — organised by the European Brain Council in collaboration with the Federation of European Neuroscience Societies (FENS) and the International Brain Research Organization (IBRO) — will bring together key stakeholders to reflect on the global burden of brain disease\, enhancing brain health and how to approach the challenges together through knowledge and data sharing\, capacity building\, funding and policy: key areas to forge a path towards stronger international alliances and a grander brain plan. \nCLICK HERE FOR REGISTRATION & PROGRAMMEFurthermore\, all event attendees are warmly invited to join us at the 1st Fundraising Gala Dinner of the European Brain Foundation later that evening. Tickets are available separately through brainfoundation.eu/gala-dinner/
URL:https://www.braincouncil.eu/event/baw2023/
ATTACH;FMTTYPE=image/jpeg:https://www.braincouncil.eu/wp-content/uploads/2022/12/BAW23-slider-scaled-e1680698557452.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230316T180000
DTEND;TZID=UTC:20230316T230000
DTSTAMP:20260415T002827
CREATED:20221209T113855Z
LAST-MODIFIED:20230125T143950Z
UID:43218-1678989600-1679007600@www.braincouncil.eu
SUMMARY:Fundraising Gala Dinner | European Brain Foundation
DESCRIPTION:Tickets are now available for the European Brain Foundation’s first Fundraising Gala Dinner\, which will take place on 16 March 2023\, in Brussels\, on the occasion of Brain Awareness Week. \nThe Gala Dinner will fall under the theme “Healthy Brains – a key to future generations in Europe”. A nod to the EBF’s core mission and goal to serve society and support those affected by brain disorders\, the theme showcases the great purpose we have to make sure that children\, teenagers\, and adolescents –  our future generations – are provided with the best tools and care to protect their brain health. Guests and donors will contribute to help the EBF’s quest to reduce the impact of one of the biggest health challenges society is currently facing. \nThe newly-formed European Brain Foundation — an independent multidisciplinary and multistakeholder charity whose founding members represent leading European neurological\, neurosurgical\, and psychiatric clinical societies as well as neuroscience research and patient organisations — was officially launched on the occasion of the 2nd in-person Brain Innovation Days on 11-12 October 2022.  \nIts goal is to support research aiming at reducing the burden of brain disorders for European citizens. By coordinating all the partners concerned in this domain\, the EBF will ensure the transparency and the sustainability of its actions. Donors will contribute to significantly reduce the impact of one of the biggest health challenges European society is currently facing.  \nFollow the EBF social media channels (Twitter\, LinkedIn\, Facebook\, Instagram) for all the latest updates!  \nDiscover the programmeGet your ticket
URL:https://www.braincouncil.eu/event/fundraising-gala-dinner-european-brain-foundation/
LOCATION:Brussels\, Belgium
ORGANIZER;CN="European Brain Foundation":MAILTO:office@brainfoundation.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230325
DTEND;VALUE=DATE:20230329
DTSTAMP:20260415T002827
CREATED:20230104T073632Z
LAST-MODIFIED:20230203T095710Z
UID:43923-1679702400-1680047999@www.braincouncil.eu
SUMMARY:31st European Congress of Psychiatry
DESCRIPTION:After 3 years of virtual congress\, we are pleased to inform you that the EPA 2023 Congress will take place in person from 25 to 28 March 2023 at the Palais des Congrès in Paris\, guided by the motto “Social Cohesion\, a Common Goal for Psychiatry”. \nInternational experts will gather to discuss the newest developments in European psychiatry. It’s important\, now more than ever\, to get together and talk about mental health care.  \nAttending EPA 2023 will give you the opportunity to network face to face with some of the world’s expert professionals within the field of psychiatry. \nEBC looks forward to being part of the Congress and having a booth in the exhibition area where our most recent publications will be displayed. \nVisit the congress websiteFor privacy reasons YouTube needs your permission to be loaded. For more details\, please see our Privacy Policy.I Accept
URL:https://www.braincouncil.eu/event/31st-european-congress-of-psychiatry/
LOCATION:Paris\, France
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230328
DTEND;VALUE=DATE:20230401
DTSTAMP:20260415T002827
CREATED:20230206T120108Z
LAST-MODIFIED:20230206T120405Z
UID:45001-1679961600-1680307199@www.braincouncil.eu
SUMMARY:Human Brain Project Summit 2023
DESCRIPTION:The Human Brain Project Summit 2023 will take place under the overarching theme “Achievements  and future of digital brain research”  in Marseille\, France\, on March 28-31\, 2023. The event will highlight the scientific achievements of the HBP at the point when the ten-year Flagship project approaches its conclusion (in Sept. 2023) and the legacy that it will leave for the brain research community. \nThe Summit will be a forum for stimulating and high-quality scientific exchange in different fields. Many European advances in the field of neurosciences\, health and applications in clinical medicine\, as well as brain-derived technologies will be presented. The programme has been carefully planned to offer you a memorable conference\, it includes lectures\, debates\, a science market\, a poster session and more… \nEBC is pleased to be a contributor this year with Frédéric DESTREBECQ\, Executive Director\, taking part in the panel discussion “Brain health: an emerging European policy priority” on 28 March 2023 at 14:45-16:00. The panel\, moderated by Paweł ŚWIEBODA (EBRAINS/HBP)\, will feature Philippe AMOUYEL (JPND/Fondation Alzheimer)\, Marlies DORLÖCHTER (ERA-NET NEURON)\, Gitte MOOS KNUDSEN (University of Copenhagen) and Stefan SCHRECK (European Commision DG SANTE).
URL:https://www.braincouncil.eu/event/human-brain-project-summit-2023/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230501
DTEND;VALUE=DATE:20230507
DTSTAMP:20260415T002827
CREATED:20230420T114108Z
LAST-MODIFIED:20230509T130452Z
UID:46655-1682899200-1683417599@www.braincouncil.eu
SUMMARY:Walking the Talk for Dementia
DESCRIPTION:Walking the Talk for Dementia is an innovative\, adventurous and immersive experience involving people working\, researching and living with dementia. \nDementia is a pressing issue for our lifetime\, and society needs to be responsive to ensure that people can live with more dignity and access to services and resources despite their diagnosis. The project’s main aim was to show that people are living with dementia despite the diagnosis\, challenges and stigma\, and that together we can rethink the way society perceives this community. The program brought together representatives from more than 20 countries on a 50km journey on the world’s most famous pilgrimage\, Santiago de Compostela\, followed by a scientific symposium led by people living with dementia. \nEBC was deligthed to be part of the Walking the Talk for Dementia Symposium and participate in the session “Building an ecosystem: Connecting for thriving” on 5 May 2023. Dominika Suchonova\, Communications & Advocacy Officer (European Brain Council)\, presented the work made in the context of the RETHINKING Alzheimer’s disease project\, calling for change in Alzheimer’s care. RETHINKING Alzheimer’s disease is a research-driven project offering policy recommendations to make tangible changes with the aim to improve the lives of people living with Alzheimer’s disease across Europe. \nFollowing the 50km Camino journey\, a documentary will be produced\, sharing the experiences of seven people living with dementia from six countries who participated in the event.
URL:https://www.braincouncil.eu/event/walking-the-talk-for-dementia/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230505T140000
DTEND;TZID=UTC:20230505T153000
DTSTAMP:20260415T002827
CREATED:20230419T120429Z
LAST-MODIFIED:20230505T084001Z
UID:46640-1683295200-1683300600@www.braincouncil.eu
SUMMARY:Policy Webinar: Animals in Research and a Pledge for Science
DESCRIPTION:A policy webinar organised by the European Brain Council in collaboration with its member organisations the Federation of European Neuroscience Societies (FENS)\, the International Brain Research Organization (IBRO) and the European College of Neuropsychopharmacology (ECNP) on the topic of Animals in Research and a Pledge for Science will be held on Friday\, 5 May 2023 from 14:00-15:30 CET. \nThis webinar\, featuring expert speakers\, aims to provide insight on the current state of research policy in the European Union and how it affects the wider brain community\, including people living with brain conditions. In line with EBC’s aim to speak with one voice for the entire community\, EBC and its member organisations find it important to involve all relevant stakeholders in its policy and advocacy work. With topics such as the use of animals in research gaining traction at the political level and widespread communication channels\, we want to ensure that the community is aware of the implications for brain research. \nFurthermore\, in mid May\, members of the EBC community will take part in a day of visits with Members of the European Parliament to shed light on a number of important issues affecting the wider brain community and calling for a Pledge for Science – for innovation\, prioritisation and overall support for the space. This webinar aims to prepare anyone wishing to gain further knowledge on key policy hot topics so important for the community’s advocacy work. \nPlease register for the webinar here. Programme details below:\n14:00-14:10\nWelcome and Opening Remarks\nProf. Suzanne Dickson\, President\, European Brain Council \n14:10-14:30\nThe European Citizens Inititiave – a threat to patient health?\nKirk Leech\, Executive Director\, European Animal Research Association (EARA) \n14:30-14:45\nAdvantages and limitations of animal- and non-animal methods\nDr Sabine Hölter-Koch\, Head of the Behavioural Unit at the German Mouse Clinic\, Helmholtz Zentrum München (Germany) and Chair\, Preclinical Data Forum Network\, European College of Neuropsychopharmacology (ECNP) \n14:45-15:00\nThe use of animals in the research investigating the application of deep brain stimulation strategies to treat addiction\nDr Christelle Baunez\, Chair\, Federation of European Neuroscience Societies (FENS) Committee on Animals in Research (CARE) \n15:00-15:20\nOpen Discussion and Q&A with Audience\nModerated by Stephanie Kramer\, Head of Communications\, Advocacy & Policy\, European Brain Council \n15:20-15:30\nConcluding Remarks
URL:https://www.braincouncil.eu/event/policy-webinar-animals-in-research-and-a-pledge-for-science/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230509T170000
DTEND;TZID=UTC:20230509T200000
DTSTAMP:20260415T002827
CREATED:20230328T075346Z
LAST-MODIFIED:20230328T075346Z
UID:46310-1683651600-1683662400@www.braincouncil.eu
SUMMARY:European Brain Health Summit 2023
DESCRIPTION:European Brain Health Summit 2023\nTuesday May 9\, 2023\, 17.00 – 20.00 CEST\n\nThe European Academy of Neurology (EAN) held two first Brain Health events in 2022: The Brain Health Summit in May in Vienna and the Brain Health Event at the European Parliament in December. Both events highlighted the importance of advocacy for neurology\, alongside cooperation with national societies\, international authorities\, organisations\, and other stakeholders. \nThis year’s Summit will focus on European Brain Health Summit: Precision neurology and prevention of neurological diseases. \nVisit the website for more information: \nProgramme
URL:https://www.braincouncil.eu/event/european-brain-health-summit-2023/
LOCATION:Livestream
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230517
DTEND;VALUE=DATE:20230520
DTSTAMP:20260415T002827
CREATED:20230131T121446Z
LAST-MODIFIED:20230131T121446Z
UID:44795-1684281600-1684540799@www.braincouncil.eu
SUMMARY:Genomics of Brain Disorders
DESCRIPTION:We are pleased to announce the fourth conference on the Genomics of Brain Disorders. This meeting will bring together international scientists and clinicians working on neurodegenerative and psychiatric diseases to compare approaches used and the emerging lessons from both categories of disease. \nPsychiatric disorders\, such as schizophrenia and depression\, and neurodegenerative disorders\, such as Alzheimer’s disease and Parkinson’s disease\, are placing an increasing burden on the developed world. Technical advances over the past few years\, including genome-wide association and next-generation sequencing studies\, have led to the discovery of many predisposing loci for both psychiatric and neurodegenerative disorders. \nThe conference will synthesise these advances and challenges in the genomics of various brain disorders. This year’s programme will explore recent insights into complex variations and genetic architecture in these disorders. We will also include sessions to discuss emerging tools and technologies\, including functional assays\, long-read sequencing\, single cell\, organoids\, and other modelling approaches. In addition\, we will highlight the methods used in population studies and how genomics is driving new therapeutics. \nWe aim to organise this meeting as a hybrid conference – with on-site or virtual attendance. If you would like to be part of these discussions – consider submitting an abstract by 21 March 2023 and register by 18 April (in-person) or 9 May (virtual) 2023. \nTo promote more inclusive scientific discussions with international colleagues at our conferences\, virtual delegates based in Lower and Middle-Income Countries can register for free. \nScientific Programme Committee: \n\nCornelis Blauwendraat – NIH/National Institute on Aging\, USA\nKristen Brennand – Yale University\, USA\nAnders Børglum – Aarhus University\, Denmark\nMina Ryten – UCL Great Ormond Street Institute of Child Health\, UK\n\nKeynote speakers: \n\nSir John Hardy – UK Dementia Research Institute at UCL\nDanielle Posthuma – Vrije Universiteit Amsterdam\, the Netherlands\n\nFor registration and further information: \nhttps://coursesandconferences.wellcomeconnectingscience.org/event/genomics-of-brain-disorders-20230517/ \nContact: conferences@wellcomeconnectingscience.org
URL:https://www.braincouncil.eu/event/genomics-of-brain-disorders/
LOCATION:Wellcome Genome Campus\, UK\, United Kingdom
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230523T090000
DTEND;TZID=UTC:20230524T170000
DTSTAMP:20260415T002827
CREATED:20230403T121309Z
LAST-MODIFIED:20230725T085629Z
UID:46439-1684832400-1684947600@www.braincouncil.eu
SUMMARY:9th Academy of National Brain Councils
DESCRIPTION:The 9th Academy of National Brain Councils (NBCs) took place on 23-24 May 2023 in Brussels\, Belgium. The annual meeting brought together NBCs representatives alongside prominent speakers and guests\, in-person and remotely\, from 15 countries: Austria\, Belgium\, Croatia\, Finland\, France\, Greece\, Italy\, Malta\, Poland\, Portugal\, Spain\, Switzerland\, Serbia\, Sweden and Turkey. \nRead the event report
URL:https://www.braincouncil.eu/event/9th-academy-of-national-brain-councils/
LOCATION:Brussels\, Belgium
ATTACH;FMTTYPE=image/png:https://www.braincouncil.eu/wp-content/uploads/2023/04/10th-Academy-of-National-Brain-Councils.png
ORGANIZER;CN="European Brain Council":MAILTO:advocacy@braincouncil.eu
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230620
DTEND;VALUE=DATE:20230625
DTSTAMP:20260415T002827
CREATED:20220803T081506Z
LAST-MODIFIED:20230414T100513Z
UID:39291-1687219200-1687651199@www.braincouncil.eu
SUMMARY:15th Congress of the European Paediatric Neurology Society (EPNS)
DESCRIPTION:The 15th Congress of the European Paediatric Neurology Society (EPNS) will take place on 20-24 June 2023 in the Congress Center Prague. \nThe main highlight of the congress is “From genome and connectome to cure”. EPNS invites you to see how the latest trends in understanding pathophysiology of neurological diseases are being implemented in clinical practice. The field has traditionally focused on precise diagnostics; however\, curative treatments were unavailable for a long time. Today\, this trend is changing rapidly and novel therapeutic options in our field have brought hope to many families of children even with the most severe neurological conditions. \nEBC looks forward to being part of the exhibition area where you will have a chance to learn more about our ongoing projects\, upcoming events and activities. \nVisit the official website and find out more! \nFor privacy reasons YouTube needs your permission to be loaded. For more details\, please see our Privacy Policy.I Accept
URL:https://www.braincouncil.eu/event/15th-congress-of-the-european-paediatric-neurology-society-epns/
LOCATION:Prague\, Czech Republic
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230701
DTEND;VALUE=DATE:20230705
DTSTAMP:20260415T002827
CREATED:20220803T133222Z
LAST-MODIFIED:20230629T130134Z
UID:39319-1688169600-1688515199@www.braincouncil.eu
SUMMARY:9th Congress of the European Academy of Neurology
DESCRIPTION:The 9th Annual Congress of the European Academy of Neurology (EAN) will take place on 1-4 July 2023 in Budapest (Hungary). The overarching theme of the congress is “Neurology beyond the Big Data”. \nThe EAN Congress will provide an unrivalled chance for our community to share a rewarding clinical and scientific experience. With the rich cultural tapestry of Budapest as our backdrop\, we also have the ideal environment for establishing new contacts and friendships\, and of course renewing old ones. \nEBC looks forward to being part of the exhibition area and holding the following sessions: \n\n1 July 2023\, 11:00-11:30: Rethinking the management of brain disorders: Alzheimer’s disease and migraine (Scientific Theatre)\n3 July 2023\, 16:15-17:15: EAN-EBC TV Studio Special Session: European Advocacy in the Brain Space \n4 July 2023\, 13:13-13:16: The role of patient representatives in the optimization of Patient Care Pathways at European level: the PKU experience (ePoster)\n\nFind out more on the official official website of the congress!
URL:https://www.braincouncil.eu/event/9th-congress-of-the-european-academy-of-neurology/
LOCATION:Budapest\, Hungary
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230701T110000
DTEND;TZID=UTC:20230701T113000
DTSTAMP:20260415T002827
CREATED:20230403T093136Z
LAST-MODIFIED:20230403T124116Z
UID:46432-1688209200-1688211000@www.braincouncil.eu
SUMMARY:EAN Congress: Rethinking the management of brain disorders: Alzheimer's disease & migraine
DESCRIPTION:The European Brain Council (EBC) is pleased to hold a Scientific Theatre on “Rethinking the management of brain disorders: Alzheimer’s disease & migraine” on 1 July 20223 at 11:00 – 11:30 during the 9th Annual Congress of the European Academy of Neurology in Budapest (Hungary). \nDespite improvements and innovation in recent years\, people living with brain conditions\, neurological and mental alike\, face variations in access to optimal treatment and care. There is a lot about brain disorders that is not fully understood and the high-quality care and support needed by people living with these conditions is often unavailable. \nThe aim of the RETHINKING Projects is to develop policy priorities around challenges in brain disorders and present a consensus on what needs to be achieved to resolve the most pressing challenges in brain conditions\, today and in the future. There is a clear need to rethink the management of the brain disorders and redesign the care pathways to ensure optimal treatment and care for all people living with brain disorders in Europe. \nThe speakers of the session will present how to rethink the way we manage Alzheimer’s disease and migraine in terms of their prevention\, detection and diagnosis. \nFind out more about the sessionSpeakersDr. Kristian Steen Frederiksen\, Co-chair\, EAN Scientific Panel Dementia and Cognitive Disorders\, European Academy of Neurology \nDr. Michela Tinelli\, Assistant Professorial Research Fellow and NIHR SSCR Leadership Fellow\, London School of Economics\, London School of Economics
URL:https://www.braincouncil.eu/event/ean-congress-rethinking-the-management-of-brain-disorders-alzheimers-disease-migraine/
LOCATION:Budapest\, Hungary
END:VEVENT
END:VCALENDAR